Nathan D . Wong

Learn More
on behalf of the American Heart Association Statistics Committee and Stroke Statistics Nathan D. Wong, Daniel Woo and Melanie B. Turner Elsayed Z. Soliman, Paul D. Sorlie, Nona Sotoodehnia, Tanya N. Turan, Salim S. Virani, Claudia S. Moy, Dariush Mozaffarian, Michael E. Mussolino, Graham Nichol, Nina P. Paynter, Lynda D. Lisabeth, Diane M. Makuc, Gregory M.(More)
Donald Lloyd-Jones, MD, ScM, FAHA; Robert Adams, MD, FAHA; Mercedes Carnethon, PhD, FAHA; Giovanni De Simone, MD; T. Bruce Ferguson, MD; Katherine Flegal, PhD*; Earl Ford, MD, MPH*; Karen Furie, MD; Alan Go, MD; Kurt Greenlund, PhD*; Nancy Haase; Susan Hailpern, DPH; Michael Ho, MD, PhD; Virginia Howard, PhD, FAHA; Brett Kissela, MD; Steven Kittner, MD;(More)
on behalf of the American Heart Association Statistics Committee and Stroke Statistics Virani, Nathan D. Wong, Daniel Woo and Melanie B. Turner Nina P. Paynter, Pamela J. Schreiner, Paul D. Sorlie, Joel Stein, Tanya N. Turan, Salim S. Darren K. McGuire, Emile R. Mohler, Claudia S. Moy, Michael E. Mussolino, Graham Nichol, Lynda D. Lisabeth, David Magid,(More)
Donald Lloyd-Jones, MD, ScM, FAHA; Robert J. Adams, MD, FAHA; Todd M. Brown, MD; Mercedes Carnethon, PhD, FAHA; Shifan Dai, MD, PhD*; Giovanni De Simone, MD; T. Bruce Ferguson, MD; Earl Ford, MD, MPH*; Karen Furie, MD; Cathleen Gillespie; Alan Go, MD; Kurt Greenlund, PhD*; Nancy Haase; Susan Hailpern, DPH; P. Michael Ho, MD, PhD; Virginia Howard, PhD, FAHA;(More)
WRITING GROUP MEMBERS Véronique L. Roger, MD, MPH, FAHA; Alan S. Go, MD; Donald M. Lloyd-Jones, MD, ScM, FAHA; Emelia J. Benjamin, MD, ScM, FAHA; Jarett D. Berry, MD; William B. Borden, MD; Dawn M. Bravata, MD; Shifan Dai, MD, PhD*; Earl S. Ford, MD, MPH, FAHA*; Caroline S. Fox, MD, MPH; Heather J. Fullerton, MD; Cathleen Gillespie, MS*; Susan M. Hailpern,(More)
. . . . . . . . . . . . . . . . . . . . . . . . . . .e29 1 . About These Statistics . . . . . . . . . . . . . . . . . . .e36 2 . Cardiovascular Health . . . . . . . . . . . . . . . . . . .e39 Health Behaviors 3 . Smoking/Tobacco Use . . . . . . . . . . . . . . . . . .e60 4 . Physical Inactivity . . . . . . . . . . . . . . . . . . . . e65 5 . Nutrition . . .(More)
BACKGROUND In white populations, computed tomographic measurements of coronary-artery calcium predict coronary heart disease independently of traditional coronary risk factors. However, it is not known whether coronary-artery calcium predicts coronary heart disease in other racial or ethnic groups. METHODS We collected data on risk factors and performed(More)
BACKGROUND Recent randomized clinical trials have suggested that estrogen plus progestin does not confer cardiac protection and may increase the risk of coronary heart disease (CHD). In this report, we provide the final results with regard to estrogen plus progestin and CHD from the Women's Health Initiative (WHI). METHODS The WHI included a randomized(More)
OBJECTIVES In a computed tomographic (CT) angiography study, we identified the characteristics of atherosclerotic lesions that were associated with subsequent development of acute coronary syndrome (ACS). BACKGROUND The CT characteristics of culprit lesions in ACS include positive vessel remodeling (PR) and low-attenuation plaques (LAP). These 2 features(More)
BACKGROUND Mortality resulting from coronary heart disease (CHD), cardiovascular disease (CVD), and all causes in persons with diabetes and pre-existing CVD is high; however, these risks compared with those with metabolic syndrome (MetS) are unclear. We examined the impact of MetS on CHD, CVD, and overall mortality among US adults. METHODS AND RESULTS In(More)